Article
Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
19 Mar 2019
Abstract excerpt
Purpose:Aim of this study was to develop a multi-gene signature to help better predict prognosis for stage III renal cell carcinoma (RCC) patients. Methods: Fourteen pairs of stage III tumor and normal tissues mRNA expression data from GSE53757 and 16 pairs mRNA expression data from TCGA clear cell renal cell carcinoma database were used to analyze differentially expressed genes between tumor and normal tissues....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
